Modakafusp Alfa
TAK-573-1001
Phase 2 small_molecule terminated
Quick answer
Modakafusp Alfa for Neoplasms is a Phase 2 program (small_molecule) at Teva Generics B.V with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Generics B.V
- Indication
- Neoplasms
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated